Chemerin level and the relation to insulin resistance in chronic kidney disease

Chemerin has been associated with different components of the metabolic syndrome, including hypertension, hyperlipidemia, and insulin resistance (IR). The aim of this study was to evaluate serum chemerin level in chronic kidney disease (CKD) patients and its relation to IR. This study was conducted...

Full description

Saved in:
Bibliographic Details
Published in:Saudi journal of kidney diseases and transplantation 2019-11, Vol.30 (6), p.1381-1388
Main Authors: El-Khashab, Sahier, Gamil, Mona, Ali, Ahmed, El-Khashab, Omar, El-Khatib, Mohamed, Mohamed, Kariman, El-Shehaby, Amal, Hamed, Soha
Format: Article
Language:English
Subjects:
Adult
Age
Aged
Blood pressure
Body mass index
Chemokines - blood
Cholesterol
Chronic kidney failure
Fasting
Female
Hemodialysis
Hepatitis
Humans
Hyperlipidemia
Hypertension
Insulin Resistance
Kidney diseases
Laboratories
Male
Metabolism
Middle Aged
Obesity
Patients
Proteins
Renal Insufficiency, Chronic - blood
Renal Insufficiency, Chronic - metabolism
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c593n-e5a7dd014c4e94d3268c68db74756ce46bc61bf0359c2b5fad8c8bdf436023353
cites cdi_FETCH-LOGICAL-c593n-e5a7dd014c4e94d3268c68db74756ce46bc61bf0359c2b5fad8c8bdf436023353
container_end_page 1388
container_issue 6
container_start_page 1381
container_title Saudi journal of kidney diseases and transplantation
container_volume 30
creator El-Khashab, Sahier
Gamil, Mona
Ali, Ahmed
El-Khashab, Omar
El-Khatib, Mohamed
Mohamed, Kariman
El-Shehaby, Amal
Hamed, Soha
description Chemerin has been associated with different components of the metabolic syndrome, including hypertension, hyperlipidemia, and insulin resistance (IR). The aim of this study was to evaluate serum chemerin level in chronic kidney disease (CKD) patients and its relation to IR. This study was conducted on 80 participants who were classified into three groups: Group I (30 CKD patients with mean age 53 ± 12 years), Group II (30 patients with end-stage renal disease on regular hemodialysis with mean age 48 ± 14.8 years) and Group III having 20 healthy age-and sex-matched controls. Serum chemerin level, fasting blood sugar, fasting insulin, HOMA-IR index calculation, urea, creatinine, estimated glomerular filtration rate, total cholesterol, and triglyceride were measured. Body composition was assessed by dual-energy X-ray absorptiometry. In Groups I and II, we found a significantly higher mean chemerin level compared to healthy controls (P
doi_str_mv 10.4103/1319-2442.275482
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_a7a3160b7f71415b8f68b2cfb13040ef</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A611233495</galeid><doaj_id>oai_doaj_org_article_a7a3160b7f71415b8f68b2cfb13040ef</doaj_id><sourcerecordid>A611233495</sourcerecordid><originalsourceid>FETCH-LOGICAL-c593n-e5a7dd014c4e94d3268c68db74756ce46bc61bf0359c2b5fad8c8bdf436023353</originalsourceid><addsrcrecordid>eNptks1vEzEQxVcIREPhzgmthIS4bPD3eo9VRKFSpV7gbHnt2caJYxd7l6j_Pd6mDQ1CPlh6_s0bzfhV1XuMlgwj-gVT3DWEMbIkLWeSvKgWhBLUUEnly2pxfD6r3uS8QYjzTojX1VnRSUckX1Q3qzXsILlQe_gNvtbB1uMa6gRejy6Geoy1C3nyhUiQXR51MFCk2qxTDM7UW2cD3NfWZdAZ3lavBu0zvHu8z6ufl19_rL431zffrlYX143hHQ0NcN1aizAzDDpmKRHSCGn7lrVcGGCiNwL3A6K8M6Tng7bSyN4OjApEKOX0vLo6-NqoN-ouuZ1O9ypqpx6EmG6VTqMzHpRuNcUC9e3QYoZ5Lwche2KGHlPEEAzF6_PB6y7FXxPkUe1cNuC9DhCnrEpDiVrZdqKgH_9BN3FKoUw6U6LjvOz4L3WrS38XhjgmbWZTdSEwLiTrZmr5H6ocCztnYoDBFf2k4NOzgjVoP65z9NP8T_kURAfQpJhzguG4IIzUHBw1J0PNyVCH4JSSD4-DTf0O7LHgKSkFWB2AffQjpLz10x6SKuw2xP2JcfPMuAgSq6eQ0T92V88B</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2336955055</pqid></control><display><type>article</type><title>Chemerin level and the relation to insulin resistance in chronic kidney disease</title><source>Medknow Open Access Medical Journals(OpenAccess)</source><source>Publicly Available Content Database</source><creator>El-Khashab, Sahier ; Gamil, Mona ; Ali, Ahmed ; El-Khashab, Omar ; El-Khatib, Mohamed ; Mohamed, Kariman ; El-Shehaby, Amal ; Hamed, Soha</creator><creatorcontrib>El-Khashab, Sahier ; Gamil, Mona ; Ali, Ahmed ; El-Khashab, Omar ; El-Khatib, Mohamed ; Mohamed, Kariman ; El-Shehaby, Amal ; Hamed, Soha</creatorcontrib><description><![CDATA[Chemerin has been associated with different components of the metabolic syndrome, including hypertension, hyperlipidemia, and insulin resistance (IR). The aim of this study was to evaluate serum chemerin level in chronic kidney disease (CKD) patients and its relation to IR. This study was conducted on 80 participants who were classified into three groups: Group I (30 CKD patients with mean age 53 ± 12 years), Group II (30 patients with end-stage renal disease on regular hemodialysis with mean age 48 ± 14.8 years) and Group III having 20 healthy age-and sex-matched controls. Serum chemerin level, fasting blood sugar, fasting insulin, HOMA-IR index calculation, urea, creatinine, estimated glomerular filtration rate, total cholesterol, and triglyceride were measured. Body composition was assessed by dual-energy X-ray absorptiometry. In Groups I and II, we found a significantly higher mean chemerin level compared to healthy controls (P <0.001), a highly significant positive correlation between mean chemerin level and the HOMA-IR index [r = 0.56, P <0.001/(r = 0.53, P <0.001)], and a highly significant negative correlation between mean chemerin level and GFR (r = -0.51, P <0.001/r = -0.46, P <0.001). In Group I, there was also a highly significant positive correlation between mean chemerin and systolic blood pressure (r = 0.31, P <0.05), diastolic blood pressure (r = 0.39, P <0.05 and creatinine (r = 0.34, P <0.05). Chemerin might be considered a uremic IR adipokine marker in CKD Stages 3, 4, and 5.]]></description><identifier>ISSN: 1319-2442</identifier><identifier>EISSN: 2320-3838</identifier><identifier>DOI: 10.4103/1319-2442.275482</identifier><identifier>PMID: 31929285</identifier><language>eng</language><publisher>Saudi Arabia: Wolters Kluwer India Pvt. Ltd</publisher><subject>Adult ; Age ; Aged ; Blood pressure ; Body mass index ; Chemokines - blood ; Cholesterol ; Chronic kidney failure ; Fasting ; Female ; Hemodialysis ; Hepatitis ; Humans ; Hyperlipidemia ; Hypertension ; Insulin Resistance ; Kidney diseases ; Laboratories ; Male ; Metabolism ; Middle Aged ; Obesity ; Patients ; Proteins ; Renal Insufficiency, Chronic - blood ; Renal Insufficiency, Chronic - metabolism</subject><ispartof>Saudi journal of kidney diseases and transplantation, 2019-11, Vol.30 (6), p.1381-1388</ispartof><rights>COPYRIGHT 2019 Medknow Publications and Media Pvt. Ltd.</rights><rights>2019. This work is published under https://creativecommons.org/licenses/by-nc-sa/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c593n-e5a7dd014c4e94d3268c68db74756ce46bc61bf0359c2b5fad8c8bdf436023353</citedby><cites>FETCH-LOGICAL-c593n-e5a7dd014c4e94d3268c68db74756ce46bc61bf0359c2b5fad8c8bdf436023353</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2336955055?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,25753,27924,27925,37012,37013,44590</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31929285$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>El-Khashab, Sahier</creatorcontrib><creatorcontrib>Gamil, Mona</creatorcontrib><creatorcontrib>Ali, Ahmed</creatorcontrib><creatorcontrib>El-Khashab, Omar</creatorcontrib><creatorcontrib>El-Khatib, Mohamed</creatorcontrib><creatorcontrib>Mohamed, Kariman</creatorcontrib><creatorcontrib>El-Shehaby, Amal</creatorcontrib><creatorcontrib>Hamed, Soha</creatorcontrib><title>Chemerin level and the relation to insulin resistance in chronic kidney disease</title><title>Saudi journal of kidney diseases and transplantation</title><addtitle>Saudi J Kidney Dis Transpl</addtitle><description><![CDATA[Chemerin has been associated with different components of the metabolic syndrome, including hypertension, hyperlipidemia, and insulin resistance (IR). The aim of this study was to evaluate serum chemerin level in chronic kidney disease (CKD) patients and its relation to IR. This study was conducted on 80 participants who were classified into three groups: Group I (30 CKD patients with mean age 53 ± 12 years), Group II (30 patients with end-stage renal disease on regular hemodialysis with mean age 48 ± 14.8 years) and Group III having 20 healthy age-and sex-matched controls. Serum chemerin level, fasting blood sugar, fasting insulin, HOMA-IR index calculation, urea, creatinine, estimated glomerular filtration rate, total cholesterol, and triglyceride were measured. Body composition was assessed by dual-energy X-ray absorptiometry. In Groups I and II, we found a significantly higher mean chemerin level compared to healthy controls (P <0.001), a highly significant positive correlation between mean chemerin level and the HOMA-IR index [r = 0.56, P <0.001/(r = 0.53, P <0.001)], and a highly significant negative correlation between mean chemerin level and GFR (r = -0.51, P <0.001/r = -0.46, P <0.001). In Group I, there was also a highly significant positive correlation between mean chemerin and systolic blood pressure (r = 0.31, P <0.05), diastolic blood pressure (r = 0.39, P <0.05 and creatinine (r = 0.34, P <0.05). Chemerin might be considered a uremic IR adipokine marker in CKD Stages 3, 4, and 5.]]></description><subject>Adult</subject><subject>Age</subject><subject>Aged</subject><subject>Blood pressure</subject><subject>Body mass index</subject><subject>Chemokines - blood</subject><subject>Cholesterol</subject><subject>Chronic kidney failure</subject><subject>Fasting</subject><subject>Female</subject><subject>Hemodialysis</subject><subject>Hepatitis</subject><subject>Humans</subject><subject>Hyperlipidemia</subject><subject>Hypertension</subject><subject>Insulin Resistance</subject><subject>Kidney diseases</subject><subject>Laboratories</subject><subject>Male</subject><subject>Metabolism</subject><subject>Middle Aged</subject><subject>Obesity</subject><subject>Patients</subject><subject>Proteins</subject><subject>Renal Insufficiency, Chronic - blood</subject><subject>Renal Insufficiency, Chronic - metabolism</subject><issn>1319-2442</issn><issn>2320-3838</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptks1vEzEQxVcIREPhzgmthIS4bPD3eo9VRKFSpV7gbHnt2caJYxd7l6j_Pd6mDQ1CPlh6_s0bzfhV1XuMlgwj-gVT3DWEMbIkLWeSvKgWhBLUUEnly2pxfD6r3uS8QYjzTojX1VnRSUckX1Q3qzXsILlQe_gNvtbB1uMa6gRejy6Geoy1C3nyhUiQXR51MFCk2qxTDM7UW2cD3NfWZdAZ3lavBu0zvHu8z6ufl19_rL431zffrlYX143hHQ0NcN1aizAzDDpmKRHSCGn7lrVcGGCiNwL3A6K8M6Tng7bSyN4OjApEKOX0vLo6-NqoN-ouuZ1O9ypqpx6EmG6VTqMzHpRuNcUC9e3QYoZ5Lwche2KGHlPEEAzF6_PB6y7FXxPkUe1cNuC9DhCnrEpDiVrZdqKgH_9BN3FKoUw6U6LjvOz4L3WrS38XhjgmbWZTdSEwLiTrZmr5H6ocCztnYoDBFf2k4NOzgjVoP65z9NP8T_kURAfQpJhzguG4IIzUHBw1J0PNyVCH4JSSD4-DTf0O7LHgKSkFWB2AffQjpLz10x6SKuw2xP2JcfPMuAgSq6eQ0T92V88B</recordid><startdate>20191101</startdate><enddate>20191101</enddate><creator>El-Khashab, Sahier</creator><creator>Gamil, Mona</creator><creator>Ali, Ahmed</creator><creator>El-Khashab, Omar</creator><creator>El-Khatib, Mohamed</creator><creator>Mohamed, Kariman</creator><creator>El-Shehaby, Amal</creator><creator>Hamed, Soha</creator><general>Wolters Kluwer India Pvt. Ltd</general><general>Medknow Publications and Media Pvt. Ltd</general><general>Medknow Publications &amp; Media Pvt. Ltd</general><general>Wolters Kluwer Medknow Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>DOA</scope></search><sort><creationdate>20191101</creationdate><title>Chemerin level and the relation to insulin resistance in chronic kidney disease</title><author>El-Khashab, Sahier ; Gamil, Mona ; Ali, Ahmed ; El-Khashab, Omar ; El-Khatib, Mohamed ; Mohamed, Kariman ; El-Shehaby, Amal ; Hamed, Soha</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c593n-e5a7dd014c4e94d3268c68db74756ce46bc61bf0359c2b5fad8c8bdf436023353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adult</topic><topic>Age</topic><topic>Aged</topic><topic>Blood pressure</topic><topic>Body mass index</topic><topic>Chemokines - blood</topic><topic>Cholesterol</topic><topic>Chronic kidney failure</topic><topic>Fasting</topic><topic>Female</topic><topic>Hemodialysis</topic><topic>Hepatitis</topic><topic>Humans</topic><topic>Hyperlipidemia</topic><topic>Hypertension</topic><topic>Insulin Resistance</topic><topic>Kidney diseases</topic><topic>Laboratories</topic><topic>Male</topic><topic>Metabolism</topic><topic>Middle Aged</topic><topic>Obesity</topic><topic>Patients</topic><topic>Proteins</topic><topic>Renal Insufficiency, Chronic - blood</topic><topic>Renal Insufficiency, Chronic - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>El-Khashab, Sahier</creatorcontrib><creatorcontrib>Gamil, Mona</creatorcontrib><creatorcontrib>Ali, Ahmed</creatorcontrib><creatorcontrib>El-Khashab, Omar</creatorcontrib><creatorcontrib>El-Khatib, Mohamed</creatorcontrib><creatorcontrib>Mohamed, Kariman</creatorcontrib><creatorcontrib>El-Shehaby, Amal</creatorcontrib><creatorcontrib>Hamed, Soha</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing &amp; Allied Health Database</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Directory of Open Access Journals(OpenAccess)</collection><jtitle>Saudi journal of kidney diseases and transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>El-Khashab, Sahier</au><au>Gamil, Mona</au><au>Ali, Ahmed</au><au>El-Khashab, Omar</au><au>El-Khatib, Mohamed</au><au>Mohamed, Kariman</au><au>El-Shehaby, Amal</au><au>Hamed, Soha</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chemerin level and the relation to insulin resistance in chronic kidney disease</atitle><jtitle>Saudi journal of kidney diseases and transplantation</jtitle><addtitle>Saudi J Kidney Dis Transpl</addtitle><date>2019-11-01</date><risdate>2019</risdate><volume>30</volume><issue>6</issue><spage>1381</spage><epage>1388</epage><pages>1381-1388</pages><issn>1319-2442</issn><eissn>2320-3838</eissn><abstract><![CDATA[Chemerin has been associated with different components of the metabolic syndrome, including hypertension, hyperlipidemia, and insulin resistance (IR). The aim of this study was to evaluate serum chemerin level in chronic kidney disease (CKD) patients and its relation to IR. This study was conducted on 80 participants who were classified into three groups: Group I (30 CKD patients with mean age 53 ± 12 years), Group II (30 patients with end-stage renal disease on regular hemodialysis with mean age 48 ± 14.8 years) and Group III having 20 healthy age-and sex-matched controls. Serum chemerin level, fasting blood sugar, fasting insulin, HOMA-IR index calculation, urea, creatinine, estimated glomerular filtration rate, total cholesterol, and triglyceride were measured. Body composition was assessed by dual-energy X-ray absorptiometry. In Groups I and II, we found a significantly higher mean chemerin level compared to healthy controls (P <0.001), a highly significant positive correlation between mean chemerin level and the HOMA-IR index [r = 0.56, P <0.001/(r = 0.53, P <0.001)], and a highly significant negative correlation between mean chemerin level and GFR (r = -0.51, P <0.001/r = -0.46, P <0.001). In Group I, there was also a highly significant positive correlation between mean chemerin and systolic blood pressure (r = 0.31, P <0.05), diastolic blood pressure (r = 0.39, P <0.05 and creatinine (r = 0.34, P <0.05). Chemerin might be considered a uremic IR adipokine marker in CKD Stages 3, 4, and 5.]]></abstract><cop>Saudi Arabia</cop><pub>Wolters Kluwer India Pvt. Ltd</pub><pmid>31929285</pmid><doi>10.4103/1319-2442.275482</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1319-2442
ispartof Saudi journal of kidney diseases and transplantation, 2019-11, Vol.30 (6), p.1381-1388
issn 1319-2442
2320-3838
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_a7a3160b7f71415b8f68b2cfb13040ef
source Medknow Open Access Medical Journals(OpenAccess); Publicly Available Content Database
subjects Adult
Age
Aged
Blood pressure
Body mass index
Chemokines - blood
Cholesterol
Chronic kidney failure
Fasting
Female
Hemodialysis
Hepatitis
Humans
Hyperlipidemia
Hypertension
Insulin Resistance
Kidney diseases
Laboratories
Male
Metabolism
Middle Aged
Obesity
Patients
Proteins
Renal Insufficiency, Chronic - blood
Renal Insufficiency, Chronic - metabolism
title Chemerin level and the relation to insulin resistance in chronic kidney disease
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T04%3A10%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chemerin%20level%20and%20the%20relation%20to%20insulin%20resistance%20in%20chronic%20kidney%20disease&rft.jtitle=Saudi%20journal%20of%20kidney%20diseases%20and%20transplantation&rft.au=El-Khashab,%20Sahier&rft.date=2019-11-01&rft.volume=30&rft.issue=6&rft.spage=1381&rft.epage=1388&rft.pages=1381-1388&rft.issn=1319-2442&rft.eissn=2320-3838&rft_id=info:doi/10.4103/1319-2442.275482&rft_dat=%3Cgale_doaj_%3EA611233495%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c593n-e5a7dd014c4e94d3268c68db74756ce46bc61bf0359c2b5fad8c8bdf436023353%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2336955055&rft_id=info:pmid/31929285&rft_galeid=A611233495&rfr_iscdi=true